Obsidian Therapeutics, Inc. (OBX) Stock
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Valuation
Financials & Margins
Latest News
Ownership
About Obsidian Therapeutics, Inc.
A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Obsidian Therapeutics, Inc. is headquartered in US.
Obsidian Therapeutics, Inc. (OBX) stock trades at $13.98 with a market capitalization of $14.54M. The stock is valued at a negative price-to-earnings (P/E) ratio of -7.85, reflecting a net loss over the last twelve months. Over the past 52 weeks the stock has ranged between $11.52 and $49.97, and currently trades 72.0% below its 52-week high.
Official website: www.obsidiantx.com
Obsidian Therapeutics, Inc. (OBX) — frequently asked questions
What is Obsidian Therapeutics, Inc. (OBX) stock price today?
Obsidian Therapeutics, Inc. (OBX) is currently trading at $13.98, up 0.29% today.
What is OBX P/E ratio?
Obsidian Therapeutics, Inc.'s P/E ratio is -7.85. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is Obsidian Therapeutics, Inc.'s market cap?
Obsidian Therapeutics, Inc. has a market capitalization of $14.54M.
Does OBX pay a dividend?
Obsidian Therapeutics, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does OBX carry?
Obsidian Therapeutics, Inc. has a debt-to-equity ratio of 0.10. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is OBX's profit margin?
Obsidian Therapeutics, Inc. reports a net profit margin of 0.00% — the share of revenue left after every cost, including tax and interest.
What sector is OBX in?
Obsidian Therapeutics, Inc. is classified under Healthcare, in the Biotechnology industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is OBX listed on?
Obsidian Therapeutics, Inc. trades on NASDAQ under the ticker OBX.
What is OBX's 52-week range?
Over the last year Obsidian Therapeutics, Inc. has traded between $11.52 and $49.97.
Related Healthcare Stocks
Popular Stocks
Screens OBX currently matches
On the figures above, Obsidian Therapeutics, Inc. passes the filters for 1 of our ready-made screens, among them Nano Cap Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.